- Poor quality anti-malarial drugs causing resistance to develop
- Quality control of drugs essential at all stages before administration
- Health professionals must be trained to detect substandard drugs
By: Sivong Sengaloundeth, 16 May 2019
Fighting malaria calls for strict quality control over drugs used against the parasite to prevent resistance.
From the cobblestone streets of Paris, France to the bustling streets of Abuja, Nigeria, health experts around the world gathered on World Malaria Day (25 April) and issued a collective cry for more action to eliminate malaria.
This year, I joined leaders from across the Greater Mekong Sub-region (GMS) in Bangkok to take stock of progress against our joint commitment to eliminate malaria in the Asia Pacific by 2030. Through better cross-border collaboration and improvements in data sharing, we have witnessed remarkable progress; in the GMS alone, cases are down by more than 75 per cent since 2012.
While this success is worthy of celebration, the region is also coming to grips with a growing challenge to this progress: drug-resistant malaria.